Fertility After Diagnosis and Management of Acquired Uterine Arteriovenous Malformation
Fertility After Diagnosis and Management of Acquired Uterine Arteriovenous Malformation
Uterine arteriovenous malformations (UAVM) are short circuits between systemic arterial and
 venous networks within the uterus. They are congenital or acquired (in the course of an
 endo-uterine gesture such as curettage or interventions such as caesareans or myomectomies).

 They can be manifested by severe metrorrhagia that can go as far as to put the patient's
 vital prognosis at risk.

 There are no recommendations for the management of UAVM since this pathology is rare and
 therefore series are performed with few cases. If some of these UAVM disappear spontaneously
 after a therapeutic abstention, when the clinical context allows it, in case of symptomatic
 UAVM, a selective embolization with arteriography is often carried out to postpone the
 hysterectomy of hemostasis.

 There are also more marginal management options such as Gonadotropin-Releasing Hormone
 agonists, methotrexate or curettage that are decided on a case by case basis depending on the
 symptoms and protocols of each medical team.

 Regarding subsequent fertility and pregnancy outcomes after conservative treatment, the
 number of studies is even lower.
Inclusion Criteria:

 -  Major patient

 -  Diagnosis of UAVM, symptomatic or not, between January 1st, 2000 and March 30th, 2017
 confirmed by imagery performed at the Rennes University Hospital

 -  Not against her participation in research

 Exclusion Criteria:

 -  Minor patient at the time of diagnosis

 -  congenital UAVM

 -  Uterine malformation

 -  Patient under legal protection (guardianship, curatorship, safeguard of justice).